Technology-assisted Methods to Advance Suicide Prevention Among Youth in Colombia
Launched by BROWN UNIVERSITY · Oct 18, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how technology can help prevent suicide and improve mental health among young people in Colombia. The study will use a digital platform designed for both youth and teachers, which includes helpful tools for mental health, a customizable safety plan, and links to online counseling services. Teachers will receive training to help them recognize when a student might be struggling and guide them to the right support. The goal is to see if these resources can reduce suicidal thoughts and behaviors in students aged 14 to 19 and improve their overall well-being.
To participate in this study, young people must be between 14 and 19 years old, attend a secondary school in Bogotá, and be open to using the digital platform. The researchers will first gather feedback from students, teachers, and parents to make sure the platform meets their needs. Participants can expect to use the digital tools and receive support from their teachers while the study evaluates how effective these methods are in helping students feel better and stay safe. This trial is an important step in building better mental health resources for young people in Colombia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria for youth:
- • aged 14-19
- • attending a secondary school in Bogota
- • willing to try the digital platform
- Exclusion Criteria for youth:
- • not meeting inclusion criteria
About Brown University
Brown University, a prestigious Ivy League institution located in Providence, Rhode Island, is committed to advancing medical research and improving public health through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Brown leverages its world-class faculty and state-of-the-art facilities to conduct rigorous studies across various fields, including medicine, public health, and biomedical sciences. The university's dedication to ethical research practices and participant safety ensures that all clinical trials are designed to yield meaningful insights that contribute to the development of new therapies and health interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bogota, , Colombia
Patients applied
Trial Officials
Alethea Desrosiers
Principal Investigator
Brown University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported